The Discounted Cash Flow (DCF) valuation of Bioventus Inc (BVS) is 16.74 USD. With the latest stock price at 8.97 USD, the upside of Bioventus Inc based on DCF is 86.6%.
Based on the latest price of 8.97 USD and our DCF valuation, Bioventus Inc (BVS) is a buy. buying Bioventus stocks now will result in a potential gain of 86.6%.
| Range | Selected | |
| WACC / Discount Rate | 6.8% - 9.2% | 8.0% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 10.61 - 34.73 | 16.74 |
| Upside | 18.3% - 287.1% | 86.6% |